289 related articles for article (PubMed ID: 10069683)
21. β
Cook RF; Bussey CT; Fomison-Nurse IC; Hughes G; Bahn A; Cragg PA; Lamberts RR
Exp Physiol; 2019 Jun; 104(6):808-818. PubMed ID: 30889297
[TBL] [Abstract][Full Text] [Related]
22. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430
[TBL] [Abstract][Full Text] [Related]
23. Relationship between beta adrenoceptor occupancy and receptor down-regulation induced by beta antagonists with intrinsic sympathomimetic activity.
Lima JJ
J Recept Signal Transduct Res; 1996; 16(5-6):357-72. PubMed ID: 8968966
[TBL] [Abstract][Full Text] [Related]
24. Effect of pretreatment with the selective beta 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and beta-adrenoceptor subtype specific occupancy of celiprolol in healthy man.
de Mey C; Beithaupt K; Palm D; Fuhr U; Belz GG
Eur J Clin Pharmacol; 1993; 44(4):341-8. PubMed ID: 8390369
[TBL] [Abstract][Full Text] [Related]
25. β
Cook RF; Bussey CT; Mellor KM; Cragg PA; Lamberts RR
Exp Physiol; 2017 Aug; 102(8):911-923. PubMed ID: 28543947
[TBL] [Abstract][Full Text] [Related]
26. In vitro evidence that carteolol is a nonconventional partial agonist of guinea pig cardiac beta1-adrenoceptors: a comparison with xamoterol.
Floreani M; Froldi G; Quintieri L; Varani K; Borea PA; Dorigo MT; Dorigo P
J Pharmacol Exp Ther; 2005 Dec; 315(3):1386-95. PubMed ID: 16160085
[TBL] [Abstract][Full Text] [Related]
27. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
28. Functional role of beta2-adrenoceptors in the transplanted human heart.
Hakim K; Fischer M; Günnicker M; Poenicke K; Zerkowski HR; Brodde OE
J Cardiovasc Pharmacol; 1997 Dec; 30(6):811-6. PubMed ID: 9436822
[TBL] [Abstract][Full Text] [Related]
29. The role of beta1 and beta2 adrenoceptors in isoproterenol-induced drinking.
Kirby RF; Novak CM; Thunhorst RL; Johnson AK
Brain Res; 1994 Sep; 656(1):79-84. PubMed ID: 7804848
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Hattori Y; Sakuma I; Nakao Y; Kanno M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
[TBL] [Abstract][Full Text] [Related]
31. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
Bundkirchen A; Brixius K; Bölck B; Schwinger RH
J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
[TBL] [Abstract][Full Text] [Related]
32. The Isoleucine at Position 118 in Transmembrane 2 Is Responsible for the Selectivity of Xamoterol, Nebivolol, and ICI89406 for the Human
Lim VJY; Proudman RGW; Monteleone S; Kolb P; Baker JG
Mol Pharmacol; 2023 Feb; 103(2):89-99. PubMed ID: 36351797
[TBL] [Abstract][Full Text] [Related]
33. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
34. A placebo controlled comparison of the effects of metoprolol and celiprolol on echo-Doppler measurements of cardiovascular function in normal volunteers.
Silke B; Thompson A; Leitch A; Riddell JG
Br J Clin Pharmacol; 1995 Jul; 40(1):37-42. PubMed ID: 8527266
[TBL] [Abstract][Full Text] [Related]
35. Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise.
Ades PA
Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):29S-33S. PubMed ID: 2894223
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular effects of clenbuterol are beta 2-adrenoceptor-mediated in steers.
Hoey AJ; Matthews ML; Badran TW; Pegg GG; Sillence MN
J Anim Sci; 1995 Jun; 73(6):1754-65. PubMed ID: 7673070
[TBL] [Abstract][Full Text] [Related]
37. Celiprolol, a potent cardioselective beta 1-adrenoceptor antagonist with mild alpha 2-adrenoceptor antagonist properties.
Wolf PS; Pruss TP; Rand MJ; Smith RD; Mann WS; Romano DV
J Hypertens Suppl; 1985 Dec; 3(3):S195-7. PubMed ID: 2908816
[TBL] [Abstract][Full Text] [Related]
38. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
[TBL] [Abstract][Full Text] [Related]
39. Partial agonist activity of celiprolol, a cardioselective beta-antagonist.
Ochi S; Nakazawa M; Kimura T; Nakagawa Y; Imai S
Eur J Pharmacol; 1991 Feb; 194(1):1-5. PubMed ID: 1676370
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of β
Mori A; Sekito A; Sakamoto K; Ishii K; Nakahara T
Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):527-533. PubMed ID: 28160015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
